|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
2009-9-23
|
|
pubmed:abstractText |
The Bevacizumab Regimens' Investigation of Treatment Effects (BRiTE) study is a prospective, observational cohort study designed to elucidate safety and effectiveness outcomes associated with bevacizumab combined with chemotherapy as used in clinical practice for first-line treatment of metastatic colorectal cancer (mCRC).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
1549-490X
|
|
pubmed:author |
pubmed-author:AshbyMark AMA,
pubmed-author:BerlinJordanJ,
pubmed-author:FlynnPatrick JPJ,
pubmed-author:GburGG,
pubmed-author:GrotheyAxelA,
pubmed-author:Investigators of the BRiTE study,
pubmed-author:KabbinavarFairooz FFF,
pubmed-author:KozloffMarkM,
pubmed-author:PurdieDavid MDM,
pubmed-author:SugrueMary MMM,
pubmed-author:YoodMarianne UlcickasMU
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
14
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
862-70
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:19726453-Adolescent,
pubmed-meshheading:19726453-Adult,
pubmed-meshheading:19726453-Aged,
pubmed-meshheading:19726453-Angiogenesis Inhibitors,
pubmed-meshheading:19726453-Antibodies, Monoclonal,
pubmed-meshheading:19726453-Antibodies, Monoclonal, Humanized,
pubmed-meshheading:19726453-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:19726453-Cohort Studies,
pubmed-meshheading:19726453-Colorectal Neoplasms,
pubmed-meshheading:19726453-Disease Progression,
pubmed-meshheading:19726453-Disease-Free Survival,
pubmed-meshheading:19726453-Female,
pubmed-meshheading:19726453-Hemorrhage,
pubmed-meshheading:19726453-Humans,
pubmed-meshheading:19726453-Hypertension,
pubmed-meshheading:19726453-Intestinal Perforation,
pubmed-meshheading:19726453-Male,
pubmed-meshheading:19726453-Middle Aged,
pubmed-meshheading:19726453-Neoplasm Metastasis,
pubmed-meshheading:19726453-Randomized Controlled Trials as Topic,
pubmed-meshheading:19726453-Thromboembolism,
pubmed-meshheading:19726453-Treatment Outcome,
pubmed-meshheading:19726453-Young Adult
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Clinical outcomes associated with bevacizumab-containing treatment of metastatic colorectal cancer: the BRiTE observational cohort study.
|
|
pubmed:affiliation |
Ingalls Hospital, Suite 401, Harvey, Illinois 60426, USA. mfkozloff@aol.com
|
|
pubmed:publicationType |
Journal Article,
Multicenter Study
|
